Related references
Note: Only part of the references are listed.Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Clinical practice guidelines for the management of liver metastases from extrahepatic primary cancers 2021
Masakazu Yamamoto et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2021)
Breast cancer liver metastasis: current and future treatment approaches
Narmeen S. Rashid et al.
CLINICAL & EXPERIMENTAL METASTASIS (2021)
Liver metastases
Diamantis I. Tsilimigras et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Simulation of 3D centimeter-scale continuum tumor growth at sub-millimeter resolution via distributed computing
Dylan A. Goodin et al.
COMPUTERS IN BIOLOGY AND MEDICINE (2021)
Nonlinear response to cancer nanotherapy due to macrophage interactions revealed by mathematical modeling and evaluated in a murine model via CRISPR-modulated macrophage polarization
Fransisca Leonard et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
The shape of breast cancer
Brook K. Byrd et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
Epidemiology of liver metastases
Samantha R. Horn et al.
CANCER EPIDEMIOLOGY (2020)
Liver Metastases and Histological Growth Patterns: Biological Behavior and Potential Clinical ImplicationsAnother Path to Individualized Medicine?
Rui Caetano Oliveira et al.
JOURNAL OF ONCOLOGY (2019)
Surgical resection versus systemic therapy for breast cancer liver metastases: Results of a European case matched comparison
A. Ruiz et al.
EUROPEAN JOURNAL OF CANCER (2018)
Simulation of Multispecies Desmoplastic Cancer Growth via a Fully Adaptive Non-linear Full Multigrid Algorithm
Chin F. Ng et al.
FRONTIERS IN PHYSIOLOGY (2018)
Model of vascular desmoplastic multispecies tumor growth
Chin F. Ng et al.
JOURNAL OF THEORETICAL BIOLOGY (2017)
Macrophage Polarization Contributes to the Anti-Tumoral Efficacy of Mesoporous Nanovectors Loaded with Albumin-Bound Paclitaxel
Fransisca Leonard et al.
FRONTIERS IN IMMUNOLOGY (2017)
Redirecting Transport of Nanoparticle Albumin-Bound Paclitaxel to Macrophages Enhances Therapeutic Efficacy against Liver Metastases
Tomonori Tanei et al.
CANCER RESEARCH (2016)
Enhanced performance of macrophage-encapsulated nanoparticle albumin-bound-paclitaxel in hypo-perfused cancer lesions
Fransisca Leonard et al.
NANOSCALE (2016)
Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases
Sophia Frentzas et al.
NATURE MEDICINE (2016)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
The Role of Mechanical Forces in Tumor Growth and Therapy
Rakesh K. Jain et al.
ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, VOL 16 (2014)
The Multifaceted Role of the Microenvironment in Liver Metastasis: Biology and Clinical Implications
Gert G. Van den Eynden et al.
CANCER RESEARCH (2013)
Hepatocyte induced re-expression of E-cadherin in breast and prostate cancer cells increases chemoresistance
Yvonne Chao et al.
CLINICAL & EXPERIMENTAL METASTASIS (2012)
Prediction of Drug Response in Breast Cancer Using Integrative Experimental/Computational Modeling
Hermann B. Frieboes et al.
CANCER RESEARCH (2009)
Chemotaxis, chemokine receptors and human disease
Tian Jin et al.
CYTOKINE (2008)
Comparative preclinical and clinical pharmacokinetics of a cremophor-free, nanoparticle albumin-bound paclitaxel (ABI-007) and paclitaxel formulated in cremophor (Taxol)
A Sparreboom et al.
CLINICAL CANCER RESEARCH (2005)
Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxia
F Stessels et al.
BRITISH JOURNAL OF CANCER (2004)
Current treatment for liver metastases from colorectal cancer
LX Liu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2003)
An attempt to clarify indications for hepatectomy for liver metastases from breast cancer
D Elias et al.
AMERICAN JOURNAL OF SURGERY (2003)
Share Paper
